Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Lancet (London, England)|March 2, 2024
National, regional, and global estimates of low birthweight in 2020, with trends from 2000: a systematic analysisYemisrach B Okwaraji, Julia Krasevec, Ellen Bradley, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 30, 2025
Neuronal α-Synuclein Disease Stage Progression over 5 YearsTanya Simuni, Caroline Gochanour, Anuprita R Nair, et al.
Parkinsonism & Related Disorders|February 11, 2019
Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI)Neha Prakash, Chelsea Caspell-Garcia, Christopher Coffey, et al.
SAGE Open Medicine|November 1, 2024
Negative effect of treatment with mGluR5 negative allosteric modulator AFQ056 on blood biomarkers in young individuals with Fragile X syndromeDragana Protic, Elizabeth Breeze, Guadalupe Mendoza, et al.
Medrxiv : the Preprint Server for Health Sciences|December 23, 2024
Impact of dopamine deficiency and REM sleep behavior disorder on cognition in early neuronal synuclein disease with hyposmiaDaniel Weintraub, Anuprita R Nair, Ryan Kurth, et al.
Plos One|May 19, 2017
Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson diseaseChelsea Caspell-Garcia, Tanya Simuni, Duygu Tosun-Turgut, et al.
Annals of Clinical and Translational Neurology|December 15, 2020
Dopamine transporter imaging predicts clinically-defined α-synucleinopathy in REM sleep behavior disorderLana M Chahine, Michael C Brumm, Chelsea Caspell-Garcia, et al.
Annals of Clinical and Translational Neurology|April 22, 2026
Prodromal Lewy Body Disorder Features in REM Sleep Behavior Disorder With Biomarker-Defined SynucleinopathyDaniel Weintraub, Michele K York, Roseanne Dobkin, et al.
Annals of Neurology|July 11, 2025
Cognitive Performance in Early Neuronal Synuclein Disease with Hyposmia but without Motor Disability: Association with Dopamine Deficiency and Isolated Rapid Eye Movement Sleep Behavior DisorderDaniel Weintraub, Anuprita R Nair, Ryan Kurth, et al.
Brain Communications|March 21, 2025
LRRK2-associated parkinsonism with and without in vivo evidence of alpha-synuclein aggregates: longitudinal clinical and biomarker characterizationLana M Chahine, David-Erick Lafontant, Seung Ho Choi, et al.
Pageof 5